Long-sen S. Chang
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 122 publications
Royal Jelly Extracellular Vesicles Enhance Diabetic Wound Healing via Inflammation Modulation, Fibroblast Migration, and Angiogenesis.
Journal: International journal of nanomedicine
Published: May 19, 2025
Corrigendum to "Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells" [Biochem. Pharmacol.188 (2021) 114544].
Journal: Biochemical pharmacology
Published: June 20, 2024
Deciphering the Genetic Links between Psychological Stress, Autophagy, and Dermatological Health: Insights from Bioinformatics, Single-Cell Analysis, and Machine Learning in Psoriasis and Anxiety Disorders.
Journal: International journal of molecular sciences
Published: April 18, 2024
ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: January 26, 2024
Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression.
Journal: Apoptosis : an international journal on programmed cell death
Published: November 03, 2023
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
Journal: Biochemical pharmacology
Published: August 09, 2023
Skin colonization by Staphylococcus aureus in hemodialysis patients with pruritus and the effect of Staphylococcus aureus-secreted α-toxin on filaggrin expression.
Journal: The Journal of dermatology
Published: August 01, 2023
BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: April 13, 2023
Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.
Journal: Toxicology and applied pharmacology
Published: February 10, 2023
AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: November 25, 2022
Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells.
Journal: Biochemical pharmacology
Published: November 11, 2022
Carboxyl Group-Modified Myoglobin Induces TNF-α-Mediated Apoptosis in Leukemia Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 12, 2022
Last Updated: 09/26/2026